Thoracic and lung involvement in familial Mediterranean fever (FMF)
Merav Lidar1, Mordechai Pras, Pnina Langevitz
1Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Israel.
Abstract:
Lung involvement in FMF is limited mainly to transient pleuritis during acute attacks. Amyloidosis of the lung is rare and is associated with symptomatic involvement of other organs while remaining subclinical in itself. Vasculitis of the lung in FMF is possible because of the strong association between FMF and a variety of vasculitides. With the exception of one case of isolated pulmonary vasculitis, vasculitis of the lung in FMF has not been described. The claim that FMF protects against asthma has not been established, but this inverse association, if present, may be traced to linkage disequilibrium in which MEFV modifies the effect of asthma and atopic-related genes, or to eosinophil function. Mesothelioma has been reported in at least four patients with FMF and is related to chronic or recurrent stimulation of the serous membrane. Three patients had peritoneal mesothelioma, while one developed mesothelioma of the lung. Finally, thromboembolism should be considered, particularly in patients with FMF amyloidosis who present with respiratory distress.
Insights
Familial Mediterranean fever (FMF) rarely involves the lungs, but can manifest as pleuritis, amyloidosis, vasculitis, mesothelioma, or thromboembolism. Further research is needed to confirm any protective effect against asthma.
Area of Science:
- Rheumatology
- Pulmonology
- Genetics
Background:
- Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
- Lung involvement in FMF is typically limited to transient pleuritis during acute attacks.
- Other pulmonary manifestations are rare but recognized complications.
Purpose of the Study:
- To review and summarize the spectrum of lung involvement in Familial Mediterranean fever.
- To discuss rare pulmonary complications associated with FMF.
- To explore potential associations between FMF and asthma.
Main Methods:
- Literature review of reported cases and studies on FMF and lung involvement.
- Analysis of the association between FMF and pulmonary conditions like amyloidosis, vasculitis, mesothelioma, and asthma.
- Discussion of underlying mechanisms and genetic factors.
Main Results:
- Lung involvement in FMF is predominantly transient pleuritis.
- Rare manifestations include pulmonary amyloidosis, vasculitis (except one isolated case), and mesothelioma.
- An inverse association with asthma is suggested but not established, possibly due to genetic linkage or eosinophil function.
- Thromboembolism is a consideration in FMF amyloidosis patients with respiratory distress.
Conclusions:
- While FMF primarily affects the pleura, rare but serious pulmonary complications can occur.
- Pulmonary amyloidosis, vasculitis, mesothelioma, and thromboembolism are potential FMF-related lung issues.
- The relationship between FMF and asthma requires further investigation.
More Related Videos
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations
